Related Experiment Video
Updated: Aug 23, 2025

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Senescence Rewires Microenvironment Sensing to Facilitate Antitumor Immunity
Hsuan-An Chen1,2, Yu-Jui Ho1, Riccardo Mezzadra1
1Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract:
Cellular senescence involves a stable cell-cycle arrest coupled to a secretory program that, in some instances, stimulates the immune clearance of senescent cells. Using an immune-competent liver cancer model in which senescence triggers CD8 T cell-mediated tumor rejection, we show that senescence also remodels the cell-surface proteome to alter how tumor cells sense environmental factors, as exemplified by type II interferon (IFNγ). Compared with proliferating cells, senescent cells upregulate the IFNγ receptor, become hypersensitized to microenvironmental IFNγ, and more robustly induce the antigen-presenting machinery-effects also recapitulated in human tumor cells undergoing therapy-induced senescence. Disruption of IFNγ sensing in senescent cells blunts their immune-mediated clearance without disabling the senescence state or its characteristic secretory program. Our results demonstrate that senescent cells have an enhanced ability to both send and receive environmental signals and imply that each process is required for their effective immune surveillance.
Significance:
Our work uncovers an interplay between tissue remodeling and tissue-sensing programs that can be engaged by senescence in advanced cancers to render tumor cells more visible to the adaptive immune system. This new facet of senescence establishes reciprocal heterotypic signaling interactions that can be induced therapeutically to enhance antitumor immunity. See related article by Marin et al., p. 410. This article is highlighted in the In This Issue feature, p. 247.
Insights
Cellular senescence enhances tumor cell visibility to the immune system by altering cell surface receptors and improving environmental sensing. This improves immune clearance of senescent cells, crucial for cancer rejection.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Cellular senescence is a state of stable cell-cycle arrest.
- Senescence is often accompanied by a secretory program that can aid immune clearance.
- Senescence can trigger CD8 T cell-mediated tumor rejection in liver cancer models.
Discussion:
- Senescence remodels the cell-surface proteome, altering how tumor cells sense environmental factors like type II interferon (IFNγ).
- Senescent cells upregulate the IFNγ receptor, becoming hypersensitive to IFNγ and enhancing antigen-presenting machinery.
- These changes are also observed in human tumor cells experiencing therapy-induced senescence.
Key Insights:
- Disrupting IFNγ sensing in senescent cells impairs their immune clearance without affecting the senescence state or secretory program.
- Senescent cells exhibit enhanced abilities in both sending and receiving environmental signals.
- Both signal sending and receiving are essential for effective immune surveillance of senescent cells.
Outlook:
- Senescence engages interplay between tissue remodeling and sensing programs to increase tumor cell visibility to the adaptive immune system.
- This facet of senescence establishes reciprocal signaling interactions that can be therapeutically induced to boost antitumor immunity.
- Further research can explore therapeutic strategies targeting these senescence-induced signaling pathways for cancer treatment.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Related Concept Videos
The Tumor Microenvironment
Replicative Cell Senescence
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy
Transduction